Leavy, O. C. et al. (2024) 1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study. ERJ Open Research, 10(5), 00474-2024. (doi: 10.1183/23120541.00474-2024) Text 339488.pdf - Published Version Available under License Creative Commons Attribution. 1MB Abstract Background: In patients with coronavirus disease 2019 (COVID-19) requiring supplemental oxygen, dexamethasone reduces acute severity and improves survival, but longer-term effects are unknown.